drugset / Trial / NCT06677827

Effect of Adding Magnesium Sulphate as Adjuvant to Bupivacaine in Ultrasound Guided External Oblique Intercostal Plane Block in Upper Abdominal Cancer Surgery.to Assess the Total Postoperative Opioid Consumption in the First 24 h and Evaluate Post Operative VAS Score

NCT06677827

Phase 4 Not yet recruiting 68 enrolled Assiut University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

double blind randomized controlled trial will be conducted on upper abdominal cancer surgery cases to study the effect of Adding Magnesium Sulphate as Adjuvant to Bupivacaine in Ultrasound Guided External Oblique Intercostal Plane Block in Upper Abdominal Cancer Surgery

Timeline

Start
2024-12-01
Primary completion
2026-12-01
Completion
2027-01-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Magnesium Sulfate Other / unclassified 200 mg Other
Background Bupivacaine Other / unclassified 0.25 % Other

Indications

No indication recorded.